Sanigen

세니젠 · 188260

Consumer Discretionary Consumer Durables · KOSDAQ

Small-cap

Market cap US$17.9M (₩24.7B)

Overview

Sanigen provides food-safety testing and sterilisation products that help food manufacturers detect harmful bacteria and viruses in their products.

Its customers are domestic and international food producers that use its diagnostic kits, genomic-analysis services, and sterilisation solutions to manage contamination risks. Listed on KOSDAQ, Korea's tech and small-cap board, the company supplies a full-cycle portfolio spanning molecular diagnostic products, laboratory consumables, and microbial-control agents under its own brands.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$11.1M

▼ −0.5% YoY

Operating profit · FY2025

−US$3.2M

Loss narrowed

Net income · FY2025

−US$4.2M

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$14.6M(₩20.2B)	US$11.2M(₩15.4B)	US$11.1M(₩15.4B)
Operating profit	−US$4.7M(−₩6.5B)	−US$4.3M(−₩5.9B)	−US$3.2M(−₩4.4B)
Net income	−US$6.7M(−₩9.2B)	−US$4.8M(−₩6.6B)	−US$4.2M(−₩5.8B)

Revenue

FY2023US$14.6M
FY2024US$11.2M
FY2025US$11.1M

Operating profit

FY2023−US$4.7M
FY2024−US$4.3M
FY2025−US$3.2M

Net income

FY2023−US$6.7M
FY2024−US$4.8M
FY2025−US$4.2M

Key ratios (FY2025)

ROE

-235.0%

Debt/Eq

308.3%

Op. margin

-28.5%

Net margin

-37.9%

Rev. YoY

▼ −0.5%

Why it matters

Sanigen absorbed a Korean special-purpose acquisition company through a merger, which was the mechanism by which it gained its current listed status on KOSDAQ.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?